Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2025
Summit Therapeutics Inc. (
NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational progress for the second quarter ended June 30, 2025.
